Abstract
The standard (glutaraldehyde-preserved) Hancock porcine bioprosthesis was introduced into clinical practice in order to provide surgeons with a cardiac valve substitute which would be nonthrombogenic and therefore would not require anticoagulation, and would be durable, anatomically suitable, and noiseless. In the present report we have reviewed our long-term experience with Hancock porcine valve recipients in order to verify the original expectations of this bioprosthesis have been met.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Bioprosthesis / standards*
-
Child
-
Follow-Up Studies
-
Glutaral / therapeutic use
-
Heart Valve Prosthesis / standards*
-
Hospitals, University
-
Humans
-
Italy / epidemiology
-
Middle Aged
-
Postoperative Complications / epidemiology
-
Postoperative Complications / etiology
-
Postoperative Complications / mortality
-
Prosthesis Failure
-
Prosthesis-Related Infections / epidemiology
-
Prosthesis-Related Infections / etiology
-
Prosthesis-Related Infections / mortality
-
Survival Rate
-
Thromboembolism / epidemiology
-
Thromboembolism / etiology
-
Thromboembolism / mortality
-
Tissue Preservation / methods